financetom
Business
financetom
/
Business
/
Cibus Tumbles After Short-Seller Report Alleges Few Commercial Products, Diminishing Resources
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cibus Tumbles After Short-Seller Report Alleges Few Commercial Products, Diminishing Resources
Jun 4, 2024 8:30 AM

11:02 AM EDT, 06/04/2024 (MT Newswires) -- Cibus ( CBUS ) was retreating in Tuesday trading, recently sinking more than 9%, following a short-seller report by Bonitas Research contending the agricultural technology firm has had little success developing viable products and is already facing intense competition from several companies inside its sector.

The Bonitas researchers also asserted that Cibus ( CBUS ) could soon run out of money after beginning its current quarter with around $24 million in cash and burning through roughly $5 million per month while generating only $200,000 in revenue each month.

"We calculate that CBUS will need to either generate significant revenues or raise capital to satisfy ongoing operating expenses by September 2024," Bonitas said in a research note on Tuesday.

Bonitas said it currently has a short position in Cibus ( CBUS ).

Cibus ( CBUS ) did not immediately reply to a request from MT Newswires seeking comment.

Price: 12.00, Change: -1.28, Percent Change: -9.64

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Concentrix Fiscal Q1 Non-GAAP Earnings Dip, Revenue Rises; Fiscal Q2, 2024 Guidance Set
Concentrix Fiscal Q1 Non-GAAP Earnings Dip, Revenue Rises; Fiscal Q2, 2024 Guidance Set
Mar 26, 2024
04:40 PM EDT, 03/26/2024 (MT Newswires) -- Concentrix ( CNXC ) reported fiscal Q1 non-GAAP earnings late Tuesday of $2.57 per diluted share, down from $2.59 a year earlier. Three analysts surveyed by Capital IQ expected $2.58. Revenue in the quarter ended Feb. 29 was $2.40 billion, up from $1.64 billion a year earlier. Four analysts surveyed by Capital IQ...
Crinetics Pharmaceuticals Insider Sold Shares Worth $1,433,675, According to a Recent SEC Filing
Crinetics Pharmaceuticals Insider Sold Shares Worth $1,433,675, According to a Recent SEC Filing
Mar 26, 2024
04:37 PM EDT, 03/26/2024 (MT Newswires) -- Jeff E. Knight, Chief Operating Officer, on March 22, 2024, sold 32,359 shares in Crinetics Pharmaceuticals ( CRNX ) for $1,433,675. Following the Form 4 filing with the SEC, Knight has control over a total of 52,580 shares of the company, with 52,580 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1658247/000120919124005081/xslF345X03/doc4.xml ...
HashiCorp Promotes Christine Centa to Chief People Officer
HashiCorp Promotes Christine Centa to Chief People Officer
Mar 26, 2024
04:41 PM EDT, 03/26/2024 (MT Newswires) -- HashiCorp ( HCP ) said late Tuesday it promoted Christine Centa as chief people officer with immediate effect. Centa was previously vice president of total rewards and people operations at HashiCorp ( HCP ). Price: 27.32, Change: +0.3, Percent Change: +1.11 ...
Western Investment Company Secures Agreement To Increase Ownership In Fortress Insurance To 43%
Western Investment Company Secures Agreement To Increase Ownership In Fortress Insurance To 43%
Mar 26, 2024
04:41 PM EDT, 03/26/2024 (MT Newswires) -- The Western Investment Company of Canada Limited (WI.V), Tuesday announced that it has secured an agreement to purchase 1 million shares in Fortress Insurance Company, or 14.22% of the total shares outstanding in Fortress, for $2.6 million. The share purchase is conditional on the closing of the previously announced proposed transaction with companies...
Copyright 2023-2026 - www.financetom.com All Rights Reserved